Source: Annual Congress 2005 - Clinical issues before and after lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Laporta, P. Ussetti, C. Garcia-Gallo, A. de Pablo, M. C. Carreno, M. J. Ferreiro (Madrid, Spain). Rapamycin in patients with chronic lung rejection. Eur Respir J 2005; 26: Suppl. 49, 4031

Member's Comments

No comment yet.

Related content which might interest you: Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Cell therapy for acute and chronic lung disease Source: International Congress 2014 – Rebuilding: new perspectives on lung bioengineering Year: 2014 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Azithromycin treatment in patients with BOS after lung transplantation Source: ISSN=ISSN 1810-6838, ISBN=, page=178 Year: 2005 Treatment options in chronic GVHD and CLAD post lung transplantation Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 TNFα-308 polymorphism associates with acute lung allograft rejection Source: Eur Respir J 2005; 26: Suppl. 49, 175s Year: 2005 Post-surgery complications in patients with chronic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006